Scientists at Harvard Medical have made a recent breakthrough in cancer therapy research with the help of three separate grants from the National Institutes of Health, totaling over $1,153,000.Read More
Science Market Update
Tags: Harvard University, breast cancer research, cancer research, Massachusetts, Longwood Medical Center, 2015, Boston, BioResearch Product Faire Event, Harvard Medical, MA, Harvard, NIH funding, research grants, breast cancer funding, NIH grants, cancer research funding, best lab supply tradeshows, best science tradeshows
Researchers at the University of Massachusetts are taking on a parasite that continues to wreak havoc in tropical climates and developing countries.Read More
People with progressive blindness conditions, such as retinitis pigmentosa, may see renewed hope for keeping their vision longer thanks to scientists at Harvard Medical School.Read More
Hypothalamic neurons orchestrate many essential physiological and behavioral processes via secreted neuropeptides, and are relevant to human diseases such as obesity, narcolepsy and infertility. A recent collaboration of scientists from New York, Toronto, and Tokyo, and Harvard Stem Cell Institute (HSCI) researchers have devised two methods for using stem cells to generate the type of neurons that help regulate behavioral and basic physiological functions in the human body, such as obesity and hypertension, as well as sleep, mood, and some social disorders.Read More
Harvard is still one of the most richly funded research universities in the world. Although much of its available monies come from private foundations and donations, Harvard also draws millions of dollars annually in government sponsored research. The 2014 most recent stats are listed below:
Researchers at the University of Massachusetts Amherst, as part of a multi-institution research team, received $4.8 million in life science funding from the National Cancer Institute as part of a five-year life science grant to research a way to target various diseases including Alzheimer’s, cancer and graft-versus-host disease (GVHD) by changing the function of an enzyme that sets in motion over 100 different protein substrates in the body.
Researchers at Harvard University have recently published the results of a human clinical trial of a therapeutic that could increase the chances of success for blood stem cell transplantation. This will be the first time that the Harvard Stem Cell Institute has brought a discovery from the lab through clinical trials, marking the success of Harvard’s nine year-old goal of conducting groundbreaking research through the institute.
Researchers at Harvard University’s Wyss Institute for Biologically Inspired Engineering recently received $3.5 million in life science funding from the NIH. The grant is called a Transformative Research Award. The NIH’s aim in creating this grant is to fund high-risk, high-reward research. According to News Medical, the NIH funded only 10 of these projects in 2013, one of which is Harvard University’s DNA-based microscopy method of viewing cells.